3773 completed, 696 recruiting, 696 terminated, 486 unknown. 6429 Phase 1, 1880 Phase 2.
Follow Urogenital Diseases: new trials by email Literature Review of Urogenital Diseases trials Research Report on Urogenital Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Device for Bladder Control for Men With SCI Noninvasive electrical stimulation device to improve bladder control - Neurogenic Bladder | Phase 1 / Phase 2 | Not yet recruiting | VA Office of Research and Development | 12 | 2028-06-01 | 2026-06-25 |
| A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy 177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended phase 2 regime - Cancer, Prostate Cancer | Phase 1 / Phase 2 | Not yet recruiting | CHU de Quebec-Universite Laval | 500 | 2028-03-01 | 2025-03-30 |
| CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP) CB-010 - Systemic Lupus Erythematosus, Lupus | Phase 1 | Withdrawn | Caribou Biosciences, Inc. | 2027-12-01 | 2025-09-19 | |
| Anti-Interleukin-6 (IL6) in Calciphylaxis Tocilizumab - Calciphylaxis | Phase 1 | Not yet recruiting | Boston Medical Center | 10 | 2027-09-01 | 2026-07-16 |
| Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS) Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] - Vesico-Ureteral Reflux | Phase 1 | Not yet recruiting | Boston Children's Hospital | 70 | 2027-07-01 | 2026-07-22 |
| REGN21353 Alone or in Combination With Nezastomig for Metastatic Castration-Resistant Prostate Cancer in Adult Participants REGN21353, Nezastomig, Sarilumab Prophylaxis (Contingency) - Metastatic Castration-Resistant Prostate Cancer, mCRPC | Phase 1 / Phase 2 | Not yet recruiting | Regeneron Pharmaceuticals | 192 | 2027-06-28 | 2026-09-30 |
| Breakthrough - T1DM and Chronic Kidney Disease Tegoprubart, Islet Cell Transplant - Diabete Type 1, Chronic Kidney Disease | Phase 1 / Phase 2 | Recruiting | University of Chicago | 10 | 2027-04-29 | 2026-08-20 |
| Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected 426c.Mod.Core-C4b, 3M-052-AF, Aluminum hydroxide suspension (Alum) - HIV Infections | Phase 1 | Not yet recruiting | HIV Vaccine Trials Network | 22 | 2027-03-30 | 2026-09-18 |
| A Study to Test New Investigational Drugs (LCFA-01and LC103) for Bacterial Vaginosis (BV) Treatment metronidazole (MTZ)+ LCFA-01 placebo + LC103 placebo, metronidazole (MTZ)+ LCFA-01 + LC103 placebo, metronidazole (MTZ)+ LC103 + LCFA-01 placebo - Bacterial Vaginosis | Phase 1 | Not yet recruiting | Massachusetts General Hospital | 280 | 2027-02-03 | 2026-10-15 |
| Little Lungs Study Calfactant, Budesonide - Invasive Mechanical Ventilation, Severe Respiratory Distress Syndrome | Phase 1 / Phase 2 | Not yet recruiting | University of Wisconsin, Madison | 24 | 2027-02-01 | 2026-11-02 |
| Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis Bupropion Hydrochloride 150 MG - End Stage Renal Disease, Fatigue | Phase 1 / Phase 2 | Not yet recruiting | The University of Texas Health Science Center at San Antonio | 16 | 2027-02-01 | 2026-11-02 |
| DK222 Study at Hopkins [18F]DK222 radiotracer - Non-Small Cell Lung Cancer, Urothelial Cancer | Phase 1 | Recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 6 | 2027-01-31 | 2026-09-29 |
| Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs ATRN-119, Stereotactic Body Radiation Therapy (SBRT) - HPV Positive Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Abramson Cancer Center at Penn Medicine | 35 | 2027-01-31 | 2026-10-27 |
| Home-Based Outpatient Model for BCG Delivery to Reduce Undue Burden on Patients Undergoing Treatment for Non-Muscle Invasive Bladder Carcinoma BCG Solution, Best Practice, Cystoscopy - Non-Muscle Invasive Bladder Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Ohio State University Comprehensive Cancer Center | 49 | 2027-01-15 | 2026-10-14 |
| Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora Autologous tissue engineered corpora - Urologic Diseases, Male Urogenital Diseases | Phase 1 | Not yet recruiting | Wake Forest University Health Sciences | 10 | 2027-01-01 | 2026-10-23 |
| Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU) ATO-101™ - Bladder Cancer | Phase 1 | Not yet recruiting | Institut Cancerologie de l'Ouest | 24 | 2027-01-01 | 2026-06-08 |
| Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures Autologous Engineered Urethral Construct - Urologic Diseases, Male Urogenital Diseases | Phase 1 | Recruiting | Wake Forest University Health Sciences | 10 | 2027-01-01 | 2026-07-28 |
| Study of ACC-1898 in Adult Participants With Advanced Solid Tumors ACC-1898 - Hepatocellular Carcinoma, Renal Cell Carcinoma | Phase 1 | Not yet recruiting | AccSalus Biosciences, Inc. | 40 | 2027-01-01 | 2026-10-28 |
| ALT-100 Monoclonal Antibody (mAb) in Bone-Predominant Metastatic Androgen Pathway Modulation Resistant (APMR) Prostate Cancer -- The ALTAR-100 Trial ALT-100 - Prostate Cancer Metastatic to Bone | Phase 1 / Phase 2 | Not yet recruiting | University of Florida | 42 | 2027-01-01 | 2026-11-04 |
| DV Plus Toripalimab With Cetirizine and Mecobalamin Pretreatment in Patients With Locally Advanced Unresectable or Metastatic Bladder Cancer Disitamab Vedotin, Toripalimab, Cetirizine - Bladder Cancer | Phase 1 | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 20 | 2027-01-01 | 2026-11-05 |
Showing 20 of 6429. Sign in to see all of them.
Prostatic Neoplasms (1065) · Ovarian Neoplasms (1024) · HIV Infections (998) · Carcinoma, Renal Cell (609) · Acquired Immunodeficiency Syndrome (507) · Breast Neoplasms (475) · Carcinoma, Non-Small-Cell Lung (473) · Renal Insufficiency (410) · Uterine Cervical Neoplasms (376) · Neoplasms (368) · Urinary Bladder Neoplasms (360) · Colorectal Neoplasms (329) · Endometrial Neoplasms (322) · Melanoma (314) · Neoplasm Metastasis (271)
Genital Diseases (4235) · Female Urogenital Diseases and Pregnancy Complications (4054) · Female Urogenital Diseases (3858) · Male Urogenital Diseases (3515) · Neoplasms by Site (3255) · Urogenital Neoplasms (3217) · Neoplasms (3051) · Urologic Diseases (2277) · Genital Diseases, Female (1766) · Kidney Diseases (1683) · Neoplasms by Histologic Type (1539) · Immune System Diseases (1527) · Genital Neoplasms, Female (1496) · Endocrine System Diseases (1456)
pembrolizumab (205) · Carboplatin (179) · Paclitaxel (172) · Cyclophosphamide (159) · Nivolumab (118) · Docetaxel (117) · Cisplatin (111) · Bevacizumab (92) · Gemcitabine (88) · fludarabine (88) · Ritonavir (70) · Zidovudine (68) · Prednisone (65) · Magnetic Resonance Spectroscopy (64) · enzalutamide (59)
National Institute of Allergy and Infectious Diseases (NIAID) (435) · National Cancer Institute (NCI) (234) · ViiV Healthcare (124) · GlaxoSmithKline (97) · AstraZeneca (83) · Merck Sharp & Dohme LLC (83) · Memorial Sloan Kettering Cancer Center (82) · Pfizer (82) · M.D. Anderson Cancer Center (80) · Novartis Pharmaceuticals (68) · Bayer (55) · Bristol-Myers Squibb (48) · Mayo Clinic (48) · Eli Lilly and Company (45) · Janssen Research & Development, LLC (39)
United States (4042) · China (516) · United Kingdom (366) · Canada (341) · Spain (312) · Australia (278) · Germany (270) · France (264) · South Korea (207) · Netherlands (170) · Belgium (164) · Italy (148) · Japan (145) · Denmark (79) · Israel (77)
PMID 40190112, PMID 25820067, PMID 32446407, PMID 33465252, PMID 23349878, PMID 25974235, PMID 31401903, PMID 34817414, PMID 34843602, PMID 36383907, PMID 39462179, PMID 16394300, PMID 22288567, PMID 30677788, PMID 32499241, PMID 32838558, PMID 34895272, PMID 36005278, PMID 37185961, PMID 39356039, PMID 40132910, PMID 40576086, PMID 16148846, PMID 16220994, PMID 18090046, PMID 19118378, PMID 19553641, PMID 19949018, PMID 20818327, PMID 22002018, PMID 22242162, PMID 22336878, PMID 22747660, PMID 22900504, PMID 22914365, PMID 23810467, PMID 23810788, PMID 24030917, PMID 24124874, PMID 24374856, PMID 24447534, PMID 25114140, PMID 25218906, PMID 25296098, PMID 25475068, PMID 25917876, PMID 25919461, PMID 26332605, PMID 27098021, PMID 27535056
2023 (57), 2019 (42), 2017 (40), 2025 (38), 2014 (35), 2016 (34), 2018 (32), 2015 (31), 2009 (23), U10CA027469 (19), P30CA033572 (18), U10CA180868 (13), P30CA015704 (12), 2008 (11), P30CA016672 (11)